pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
bemcentinib
Non-Small Cell Lung Cancer
Tyrosine-protein kinase receptor UFO
Oncoinvent ASA
0 catalysts
Phase 3
bemdaneprocel
Parkinson's Disease
BlueRock Therapeutics LP
0 catalysts
Phase 2
bempikibart
Alopecia Areata
$QTTBQ32 Bio Inc.
0 catalysts
← prev
page 188 of 271
next →
131
Pain89
Neurology1
Preclinical
bendamustine
bendamustine [INN]
Chronic Lymphocytic Leukemia (CLL)
Exinda Therapeutics LLC
0 catalysts
Marketed
bendamustine hydrochloride
Belrapzo (bendamustine hydrochloride)
B-Cell Non-Hodgkin Lymphoma
Eagle Pharmaceuticals Inc
0 catalysts
Marketed
bendamustine hydrochloride Aurobindo
Bendamustine Hydrochloride (bendamustine hydrochloride)
Chronic Lymphocytic Leukemia (CLL)
Aurobindo Pharma USA Inc
0 catalysts
pre_registration
benralizumab
Fasenra (benralizumab)
Hypereosinophilic Syndrome
Interleukin-5 receptor subunit alpha
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
benserazide hydrochloride
Beta Thalassaemia
Aromatic-L-amino-acid decarboxylase
Phoenicia Biosciences Inc
0 catalysts
pre_registration
bentracimab
Bleeding And Clotting Disorders
Serb SAS
0 catalysts
Phase 2
benzalkonium chloride + polyhexanide
benzalkonium chloride [INN] + polyhexanide [INN]
Onychomycosis (Tinea Unguium)
$TTRXTurn Therapeutics Inc.
0 catalysts
Marketed
benzgalantamine DR
Zunveyl (benzgalantamine)
Dementia Associated With Alzheimer's Disease
AlphaCognition Inc
0 catalysts
Marketed
benznidazole
Benznidazole (benznidazole)
Chagas Disease (American Trypanosomiasis)
Exeltis USA Inc
0 catalysts
Marketed
benzoyl peroxide
Epsolay (benzoyl peroxide)
Rosacea
Galderma Laboratories LP
0 catalysts
Marketed
benzphetamine
Benzphetamine Hydrochloride (benzphetamine [INN])
Obesity
KVK-Tech Inc
0 catalysts
Marketed
benztropine mesylate
Benztropine Mesylate (benztropine mesylate)
Extrapyramidal Symptoms
Leading Pharma LLC
0 catalysts
Marketed
benzylpenicillin
Penicillin G Potassium (benzylpenicillin [INN])
Actinomycosis
Avenacy Inc
0 catalysts
Phase 2
beperminogene perplasmid
Collategene (beperminogene perplasmid [INN])
Arteriosclerosis
AnGes Inc
0 catalysts
Marketed
bepotastine besilate
Bepotastine Besilate (bepotastine besilate)
Allergic Conjunctivitis
Mylan Pharmaceuticals Inc
0 catalysts
Marketed
bepotastine besylate
Bepreve (bepotastine besylate)
Allergic Conjunctivitis
$BLCOBausch & Lomb Corp
0 catalysts
Phase 2
bepranemab
Alzheimer's Disease
Microtubule-associated protein tau
UCB SA
0 catalysts
Marketed
beractant
Survanta (beractant)
Neonatal Respiratory Distress Syndrome
$ABBVAbbVie Inc.
0 catalysts
Phase 2
berberine ursodeoxycholate
Primary Sclerosing Cholangitis
HighTide Therapeutics Inc
0 catalysts
Marketed
berdazimer sodium
Zelsuvmi (berdazimer sodium [INN])
Acne Vulgaris
$PTHSPelthos Therapeutics Inc.
0 catalysts
Marketed
beremagene geperpavec
Vyjuvek (beremagene geperpavec-svdt)
Dystrophic Epidermolysis Bullosa
$KRYSKrystal Biotech, Inc.
0 catalysts
Phase 2
beroterkib
Solid Tumor
$MOSMOSAIC CO
0 catalysts
Phase 2
bersiporocin
Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical Co Ltd
0 catalysts
Marketed
besifloxacin hydrochloride
Besivance (besifloxacin hydrochloride)
Bacterial Conjunctivitis
$BLCOBausch & Lomb Corp
0 catalysts
Phase 1
besufetamig
besufetamig [INN]
Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy
Ono Pharmaceutical Co Ltd
0 catalysts
Phase 2
betahistine dihydrochloride
Vertigo
$CYTOFAltamira Therapeutics Ltd.
0 catalysts
Marketed
betaine
Betaine
Homocystinuria
$ETONEton Pharmaceuticals, Inc.
0 catalysts